No Data
There's No Escaping FibroGen, Inc.'s (NASDAQ:FGEN) Muted Revenues Despite A 34% Share Price Rise
FibreGen Shares Are Trading Higher. The Stock May Be Moving on Continued Strength Following a Q3 Earnings Beat Reported on Tuesday.
Express News | FibreGen Shares Are Trading Higher. The Stock May Be Moving on Continued Strength Following a Q3 Earnings Beat Reported on Tuesday
FibroGen Reports Strong Q3 Growth and Future Plans
FibroGen, Inc. (FGEN) Q3 2024 Earnings Conference Call Transcript Summary
FibroGen, Inc. (FGEN) Q3 2024 Earnings Conference Call Transcript
No Data
My guess is they are going to keep their doors open just long enough to sell off what little owning interest they have in the two remaining collaborative drug candidates